Universal reference book for medicines
Name of the preparation: TENOTEN

Active substance: nonappropriate

Type: Nootropic drug with anxiolytic activity

Producer: NPF Materia Medica Holding (Russia)
Composition, form of production and packaging
Tablets for resorption from white to almost white, flat-cylindrical, with a risk and facet; on the flat side, the inscription "MATERIA MEDICA" is painted with a risk, on the other flat side there is the inscription "TENOTEN".
1 tab.

antibodies to the brain-specific protein S-100 affinely purified 3 mg *

[PRING] lactose monohydrate - 267 mg, microcrystalline cellulose - 30 mg, magnesium stearate - 3 mg.

* are applied to lactose in the form of a water-alcohol mixture with a content of no more than 10 -15 ng / g of the active form of the active substance.

20 pcs.
- packings of cellular contour (1) - packs cardboard.
20 pcs.
- packings cellular planimetric (2) - packs cardboard.

Description of the drug approved by the manufacturer for the printed edition of 2016.


The drug has a soothing, anti-anxiety (anxiolytic) effect, without causing undesirable hypnogenic and muscle relaxant effects.
It improves the tolerance of psychoemotional loads. Has a stress-protective, nootropic, anti-amnestic, antihypoxic, neuroprotective, anti-asthenic, antidepressant action.
In conditions of intoxication, hypoxia, in conditions after acute disturbance of cerebral circulation, it has a neuroprotective effect, limits the damage zone, normalizes the learning and memory processes in the central nervous system.

Inhibits the processes of lipid peroxidation.

Modifies the functional activity of the S-100 protein, which conjugates the synaptic (information) and metabolic processes in the brain.
Providing GABA-mimetic and neurotrophic action, increases the activity of stress-limiting systems, helps restore the processes of neuronal plasticity.

- neurotic and neurosis-like conditions;

- psychosomatic diseases;

- Stressor disorders with increased nervous tension, irritability, anxiety and vegetative reactions;

- Moderately severe organic lesions of the central nervous system, incl.
traumatic and discirculatory origin, accompanied by an unstable emotional background, irritability, memory loss, vegetative disorders.

At one time - 1 or 2 tablets. (keep in your mouth until completely dissolved - not during meals). Take 2 times / day; if necessary, up to 4 receptions / day. The course of treatment - 1-3 months; If necessary, the course of treatment can be extended to 6 months or repeated after 1-2 months.
If there is no persistent improvement in the condition within 3-4 weeks after the start of treatment, you should consult a doctor.


When used for the indicated indications and in the indicated dosages, there was no side effect.

Possible reactions of increased individual sensitivity to the components of the drug.


- children's age till 18 years;

- increased individual sensitivity to the components of the drug.

Children and adolescents under the age of 18 years are shown the use of the drug Tenoten for children.


The safety of Tenoten during pregnancy and lactation has not been studied.
If necessary, the drug should take into account the risk / benefit ratio.

Contraindicated use of the drug for children and adolescents under the age of 18 years.

Children and adolescents under the age of 18 years are shown the use of the drug Tenoten for children.


The composition of the drug includes lactose, and therefore it is not recommended for patients with congenital galactosemia, glucose malabsorption syndrome or galactose, or with congenital lactase insufficiency.

In connection with the presence in the action of the drug Tenoten activating properties, the last method to exercise no later than 2 hours before bedtime.


There have been no cases of overdose to date.


Cases of incompatibility with others
medicinal products have not been registered to date.

The drug is approved for use as a means of OTC.


The drug should be stored in a child not reachable at a temperature of no higher than 25 В° C.
Shelf life - 3 years.
During the period of application of the preparation, store the contour mesh package in a cardboard bundle provided by the manufacturer.

Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y

Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!